Our study demonstrates the participation of PAD2 and PAD4 enzymes genetic polymorphisms in the susceptibility to develop interstitial lung disease (ILD) in individuals with rheumatoid arthritis (RA) as well as the increase in PAD4 levels in subjects carrying risk genotypes in genes that code for this enzyme. The gene discussed is PADI2; the disease is rheumatoid arthritis.